Members only

Raising the standard in deliverability

When it comes to biodegradable polymer technology, Biosensors has developed the highest level of expertise and delivered the best results in terms of safety and efficacy.
BioMatrix NeoFlex is a stainless steel DES with an enhanced stent delivery system brings exceptional performance in complex lesions and challenging anatomies.
With the LEADERS1 trial 5-year results BioMatrix NeoFlex™ achieved Gold Standard status in biodegradable technology.

The enhanced deliverability of BioMatrix NeoFlex™ does not compromise longitudinal or radial strength7, allowing delivery of our proprietary Limus drug BA9™ to even the most complex and difficult to reach lesions. This enhanced technical performance, and confidence from the results seen in the extensive clinical trial program, make the stent an excellent choice for your workhorse DES.

 


Abluminal coating absorb after 6 to 9 months*

No drug carrier or drug inside the stent
  • Early BMS-like endothelial coverage1
  • More targeted drug release
  • Reduced systemic exposure

 

11184-000-EN - Rev.03 + 10801-000-EN - Rev.05 + 10833-000-EN - Rev.03 + 11582-000-EN - Rev.01 + 11881-000-EN - Rev.04
BioMatrix NeoFlex™
Movie - How does it work?
Watch the working principle of our BioMatrix NeoFlex™ stent
BioMatrix NeoFlex™
Main brochure

BioMatrix NeoFlex™
Ordering information

* In vivo testing in porcine model demonstrates abluminal coating is absorbed after 6 to 9 months. Data on file at Biosensors International
1. Data on file at Biosensors International
7. 11582-000-EN – Rev.01
 
BIOMATRIX™ FAMILY CLINICAL PROGRAM

 

CAUTION: Please note that the following pages are exclusively reserved for Health Care Professionals in countries with applicable health authority product registrations. To the extent this site contains information intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions. Please contact your Biosensors International representative for availability or the products and registration status.

The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology products, including BioMatrix NeoFlex™, BioMatrix™ Alpha, BioFreedom™, BioFreedom™ Ultra, Chroma™, BioStream™, BMX-J®, BioPath™, Powerline™, RISE™ NC, are not available for sale in the United States and certain other countries. ALLEGRA™ is a product of NVT AG. Blue Sail Medical Co., Ltd is the parent company of NVT AG and Biosensors International Group, Ltd. and its affliates are collaborating for the commercialization of the ALLEGRA™ device.

BioMatrix NeoFlex, BioMatrix Alpha, BioFreedom, BioFreedom Ultra, Chroma, BioStream, BMX-J, BioPath, Juno, S-Stent, Powerline, Rise NC and Quadrature Link are trademarks or registered trademarks of Biosensors International Group, Ltd. ALLEGRA is a trademark or registered trademark of NVT AG. ALLEGRA™ is CE Mark approved (CE 0124). All other cited trademarks are the property of their respective owners.